| Apixaban in Patients with Left Ventricular Thrombus, CLEAN-LV Study |
Ongoing |
Apixaban |
4 |
2018-08 |
Saud Al-Babtain Cardiac Center (Dammam)N/A |
| An observational, prospective cohort study to evaluate the safety and effectiveness of Remsima® in the treatment of inflammatory bowel disease among Saudi Arabia patients diagnosed with Crohn’s disease, ulcerative colitis, or fistulizing CD |
Ongoing |
Remsima |
4 |
RMS-KSA-20 |
King Abdulaziz University Hospital (Jeddah) |
| Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma |
Ongoing |
Ibrutinib |
3 |
A051301 |
King Faisal Specialist Hospital and Research Center (Riyadh) |
| OPEN LABEL, RANDOMIZED, SINGLE SITE CLINICAL TRIAL TO COMPARE THE SAFETY & EFFICACY OF HERBAL MELANIN EXTRACTED FROM NIGELLA SATIVA SEEDS VS STANDARD OF CARE TREATMENT IN TREATING GASTRITIS PATIENTS |
Rejected |
Melanole NIGELLA SATIVA |
2 |
RC15/152/R |
N/A |
| Randomized, two-way, two-period, single injectable dose, open-label, crossover, bioequivalence study to compare Enoxa pre-filled syringes (80 mg enoxaparin sodium) versus Clexane® pre-filled syringes (80 mg enoxaparin sodium), in healthy subjects under fasting condition. |
Ongoing |
Enoxa / Enoxaparin |
BE |
21-2017 v.02 |
Saudi Ajal |
| "A 12-week, multicenter, randomized, double-blind, placebo-controlledstudy to assess the efficacy and safety of QAW039 when added tostandard-of-care asthma therapy in patients with uncontrolled asthma" |
Ongoing |
QAW039/Fevipiprant |
3 |
CQAW039A2316 |
King Fahad Medical City (Riyadh), King Abdulaziz Medical City NG (Jeddah) |
| ATOS study_A 12–month prospective observational study assessing the real-world clinical effectiveness, safety and health-economic benefits of Toujeo® initiation after oral antidiabetic drug failure in insulin-naïve patients with type 2 diabetes mellitus |
Ongoing |
TOUJEO |
4 |
OBS14708 |
King Abdulaziz University Hospital (Jeddah), Dr. Ghassan N. Pharaon General Hospital (Jeddah), Dallah Hospital (Riyadh), Alzafer Hospital (Najran), Dr. Bakhsh Hospital (Jeddah), Saudi German Hospital (Jeddah), Arrawdha General Hospital (Dammam), Almana Hospital (Jubail), Almouwasat Hospital (Dammam), Specialized Medical Center (Riyadh) |
| "A 2-treatment period, randomized, placebo-controlled,multicenter parallel-group study to assess the safety ofQAW039 when added to existing asthma therapy in GINAsteps 3, 4 and 5 patients with uncontrolled asthma" |
Ongoing |
QAW039/Fevipiprant |
3 |
CQAW039A2315 |
King Fahad Medical City (Riyadh), King Abdulaziz Medical City NG (Jeddah) |
| Randomized, four-way, four-period, single oral dose, open-label, crossover, bioequivalence study to compare Tacrolimus Immediate-release capsules (5 mg tacrolimus) versus Prograf® Immediate-release capsules (5 mg tacrolimus), in healthy subjects under fasting conditions. |
Ongoing |
Tacrolimus/ Prograf |
BE |
19-2017 |
Saudi Ajal |
| A Randomized, Open-Label, Phase 3 Study of Abemaciclib combined with Standard Adjuvant Endocrine Therapy versus Standard Endocrine Therapy Alone in Patients with High Risk Node Positive Early Stage Hormone Receptor Positive, Human Epidermal Receptor 2 Negative Breast Cancer |
Ongoing |
abemaciclib |
3 |
I3Y-MC-JPCF |
King Fahad Medical City (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh), King Fahad Specialist Hospital (Dammam) |
